Chongqing Huapont Shengchem Pharmaceutical Co., Ltd, founded in 1994, is the wholly owned subsidiary of Chongqing Huapont Pharmaceutical Co.，Ltd, a member of Huapont Life Science Co., Ltd. which is a non-state owned public company listed in Shenzhen Stock Exchange (#002004). The company provide integrated services of R&D, production, CDMO and sale of intermediates and APIs for domestic and overseas market.

The company locates in Chongqing, with 2 production site and 1 R&D center. Huapont Shengchem is committed to become the most reliable and distinctive API supplier with highly effective service platform. Over 20 years’ development, its API products have been registered and sold in more than 60 countries including China, the United States, Canada, the European Union (EDQM), Japan, South Korea, Vietnam, Australia, Brazil, etc., Now the company becomes as one of the most reliable suppliers of many large pharmaceutical companies at home and overseas.

The company always insist with the strategy of technological innovation, undertake CDMO with excellent R&D ability and production capacity; and provide efficient, flexible and high-quality one-stop solutions for our global partner with both intermediates and API from different quantity level.

The company's products are mainly involved in more than 20 treatment areas, such as anti-tumor, dermatology, respiratory and anti-infection. The key products include a full range of retinoic acids, such as Tretinoin, Alitretinate, Isotretinoin, vitamin D3 of Calcipotriol, Paricalcitol, anti-tumor and adjuvant products such as Bendamustine HCl, Bexarotene, Calcium folinate, etc.

Huapont Shengchem adheres to the corporate culture of "unity, fair, honest and dedication", dedicates to provide good services with high-quality products, strives to become a high-quality supplier of global characteristic API.